Table 2.

Treatment-related side effects

Side effects	Possible treatment related*, Patients (%)	Probable treatment related** Patients (%)	All treatment-related events Patients (%)
Fatigue	2 (9.1) grade 1	1 (4.5) grade 1	3 (13.6)
Injection site reaction	2 (9.1) grade 1	18 (81.8) grade 1	22 (100)
		4 (18.2) grade 2
Viral upper respiratory tract infection	1 (4.5) grade 1		1 (4.5)
Headache	1 (4.5) grade 1		1 (4.5)
Paraesthesia	1 (4.5) grade 1		1 (4.5)
Hot flush	1 (4.5) grade 1	1 (4.5) grade 1	2 (9.1)
Total no of patients†	6 (27.3)	22 (100)	22 (100)

Clinical events, including laboratory test abnormality, with a reasonable time sequence to administration of the vaccine, (*) which can also be explained by concurrent disease or other drugs or chemicals, or (**) which can unlikely be attributed to concurrent disease or other drugs or chemicals.

† Indicates the total number of patients reporting at least one event.